Home Cart 0 Sign in  

[ CAS No. 1285515-21-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1285515-21-0
Chemical Structure| 1285515-21-0
Structure of 1285515-21-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1285515-21-0 ]

Related Doc. of [ 1285515-21-0 ]

Alternatived Products of [ 1285515-21-0 ]

Product Details of [ 1285515-21-0 ]

CAS No. :1285515-21-0 MDL No. :MFCD22665702
Formula : C24H18FN3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :WCIGMFCFPXZRMQ-UHFFFAOYSA-N
M.W : 399.42 Pubchem ID :68107965
Synonyms :
Chemical Name :2-(Benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide

Calculated chemistry of [ 1285515-21-0 ]

Physicochemical Properties

Num. heavy atoms : 30
Num. arom. heavy atoms : 24
Fraction Csp3 : 0.04
Num. rotatable bonds : 7
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 112.62
TPSA : 64.11 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.8 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.74
Log Po/w (XLOGP3) : 4.14
Log Po/w (WLOGP) : 5.19
Log Po/w (MLOGP) : 2.84
Log Po/w (SILICOS-IT) : 4.96
Consensus Log Po/w : 3.97

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.05
Solubility : 0.00352 mg/ml ; 0.00000882 mol/l
Class : Moderately soluble
Log S (Ali) : -5.19
Solubility : 0.00256 mg/ml ; 0.0000064 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -9.55
Solubility : 0.000000112 mg/ml ; 0.0000000003 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 2.97

Safety of [ 1285515-21-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1285515-21-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1285515-21-0 ]
  • Downstream synthetic route of [ 1285515-21-0 ]

[ 1285515-21-0 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 1285513-32-7 ]
  • [ 401815-98-3 ]
  • [ 1285515-21-0 ]
YieldReaction ConditionsOperation in experiment
62.2% With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In 1,2-dimethoxyethane; water for 2 h; Reflux A solution of 6g (771 mg, 2.012 mmol), (2-fluoro-4-pyridinyl)boronic acid (425 mg, 3.02 mmol),bis(triphenylphosphine)palladium(II) chloride (70.6 mg, 0.101 mmol) and Na2CO3 (1066 mg,10.06 mmol) in DME (20 mL) and water (2 mL) was stirred at reflux for 2 hours. The mixturewas then diluted with EA (50 mL) and water (50 mL). The organic layer was separated and theaqueous layer was extracted with ethyl acetate (50 mL*2). The combined organic layer wasconcentrated and the crude was purified by silica gel eluting with 0-10percent MeOH/DCM (1percentammonia) to give the title compound 8i (500 mg, 1.252 mmol, 62.2 percent yield) as an off-white solid.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
[2] Patent: WO2011/38572, 2011, A1, . Location in patent: Page/Page column 158; 159
  • 2
  • [ 462-08-8 ]
  • [ 1285515-21-0 ]
Reference: [1] Patent: WO2011/38572, 2011, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
[3] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
  • 3
  • [ 89-55-4 ]
  • [ 1285515-21-0 ]
Reference: [1] Patent: WO2011/38572, 2011, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
[3] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
  • 4
  • [ 62176-31-2 ]
  • [ 1285515-21-0 ]
Reference: [1] Patent: WO2011/38572, 2011, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
  • 5
  • [ 850350-09-3 ]
  • [ 1285515-21-0 ]
Reference: [1] Patent: WO2011/38572, 2011, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
Same Skeleton Products
Historical Records